Clinical factors affecting quality of the response to Stelara for psoriasis

Linear Mode

Clinical factors affecting quality of the response to Stelara for psoriasis

mataribot Offline

100 + Member I Just Cant Stop !

Posts: 1,306
Threads: 38
Joined: Jun 2013
Gender: Male
Location: USA
Treatment: >_<

Thu-10-07-2014, 01:04 AM

"The patients, who showed a <74% reduction in the PASI score, were classified as insufficient-responders." That's just an insanely high tolerance. Fred, I bet you would be considered a insufficient responder. Sounds like someone doesn't want to pay for treatment.

Quote

« Next Oldest | Next Newest »

Messages In This Thread

Clinical factors affecting quality of the response to Stelara for psoriasis - by Fred - Wed-09-07-2014, 20:20 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by jiml - Wed-09-07-2014, 20:37 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Fred - Wed-09-07-2014, 20:49 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by jiml - Wed-09-07-2014, 20:58 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Fred - Wed-09-07-2014, 21:05 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Bill - Thu-10-07-2014, 00:17 AM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by mataribot - Thu-10-07-2014, 01:04 AM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Caroline - Thu-10-07-2014, 07:17 AM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by mataribot - Thu-10-07-2014, 07:36 AM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Bill - Thu-10-07-2014, 13:31 PM

Possibly Related Threads…
Thread		Author	Replies	Views	Last Post
	Stelara vs Tremfya German study	Fred	1	2,086	Thu-20-07-2023, 07:24 AM Last Post: Caroline
	Tremfya vs Stelara Italian study	Fred	2	2,384	Fri-27-01-2023, 12:39 PM Last Post: Fred
	Otezla (apremilast) quality of life, efficacy, and safety study	Fred	1	1,960	Tue-01-11-2022, 03:14 AM Last Post: mataribot
	Tremfya super response study	Fred	4	3,395	Thu-04-08-2022, 19:34 PM Last Post: mataribot
	IMG-004 starts phase I clinical trial	Fred	2	2,073	Tue-17-05-2022, 06:48 AM Last Post: Caroline

Users browsing this thread: 2 Guest(s)

Login
Username:
Password:	Lost Password?
	Remember me